Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the nurses' health study and the health professionals' follow-up study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 2, 2008, Pages 311-319

  Hazra, Aditi ^a,b   Chanock, Stephen ^d   Giovannucci, Edward ^a,b   Cox, David G ^a,b   Niu, Tianhua ^a   Fuchs, Charles ^b,c   Willett, Walter C ^a,b   Hunter, David J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK ASSESSMENT; VARIATION (GENETICS);

EID: 39449133283     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0195     Document Type: Article

References (32)

1. American Cancer Society. Cancer facts and figures. 2006.
2. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32:D528-32.
3. A haplotype map of the human genome. Nature 2005;437:1299-320.
4. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617-21.
5. Steemers FJ, Gunderson KL. Illumina, Inc. Pharmacogenomics 2005;6:777-82.
6. Foster CB, Aswath K, Chanock SJ, McKay HF, Peters U. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet 2006;7:56.
7. Hughes AL, Packer B, Welch R, Chanock SJ, Yeager M. High level of functional polymorphism indicates a unique role of natural selection at human immune system loci. Immunogenetics 2005;57:821-7.
8. Hunter DJ, Riboli E, Haiman CA, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005;5:977-85.
9. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev 2005;14:863-70.
10. 6- methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States). Cancer Causes Control 2006;17:721-31.
11. Garcia-Closas M, Malats N, Real FX, et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007;3:e29.
12. Tranah GJ, Lescault PJ, Hunter DJ, De Vivo I. Multiple displacement amplification prior to single nucleotide polymorphism genotyping in epidemiologic studies. Biotechnol Lett 2003;25:1031-6.
13. Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT. Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 2006;15:2533-6.
14. SAS. Genetics user's guide. Cary: SAS Institute, Inc.; 2002.
15. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
16. Rothe C, Koszycki D, Bradwejn J, et al. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 2006;31:2237-42.
17. Sunyaev S, Ramensky V, Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 2000;16:198-200.
18. Webb EL, Rudd MF, Sellick GS, et al. Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. Hum Mol Genet 2006;15:3263-71.
19. 6-methylguanine-DNA methyltransferase. EMBO J 1982;1:1359-63.
20. Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem 2006;281:14529-32.
21. 6-methylguanine- DNA methyltransferase activity: analyses of three residues at or near the methyl acceptor site. Carcinogenesis 1992;13:837-43.
22. Linsalata M, Giannini R, Notarnicola M, Cavallini A. Peroxisome proliferator-activated receptor γ and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 2006;6:191.
23. Babbar N, Gerner EW, Casero RA, Jr. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 2006;394:317-24.
24. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005;219:125-35.
25. Modrich P. Mechanisms and biological effects of mismatch repair. Annu Rev Genet 1991;25:229-53.
26. Stevens RG, Morris JE, Cordis GA, Anderson LE, Rosenberg DW, Sasser LB. Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. Free Radic Biol Med 2003;34:1212-6.
27. Shaheen NJ, Silverman LM, Keku T, et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 2003;95:154-9.
28. Chan AT, Ma J, Tranah GJ, et al. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst 2005;97:917-26.
29. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593-628.
30. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-10.
31. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Catechol- O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001;61:6716-22.
32. Thompson PA, Shields PG, Freudenheim JL, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998;58:2107-10.